Kither Biotech
Turin, Italy· Est.
Kither Biotech develops novel therapies for respiratory diseases, focusing on pulmonary arterial hypertension and cystic fibrosis.
Private Company
Total funding raised: $37.5M
About
Kither Biotech develops novel therapies for respiratory diseases, focusing on pulmonary arterial hypertension and cystic fibrosis.
RNA & Gene TherapySmall Molecules
Funding History
3Total raised:$37.5M
Series B$25M
Series A$10M
Seed$2.5M